Web Images Videos Maps News Shopping Gmail more »
Sign in
Go to Blog Search Home

  
  Advanced Blog Search
  Preferences
 Blog resultsResults 1 - 10 of about 81 for perindopril litigation. (0.14 seconds) 
Browse Top Stories
Published
Anytime

Subscribe:
Blogs Alerts Blogs Alerts
Atom | RSS
Sorted by relevance    Sort by date
 
The IPKat - supporting prudent IP use: Servier perindopril "try-on ...
9 May 2008 by noreply@blogger.com (Jeremy)  
Fact is: litigation in Duesseldorf is ADR beefed up with injunctions, not adversarial litigation with exposure of the real facts. Friday, May 09, 2008 11:02:00 PM. Anonymous said... Perindopril is not going any where. ...
The IPKat - supporting prudent IP use - http://ipkitten.blogspot.com/ - References
[ More results from The IPKat - supporting prudent IP use ]

the peril of perindropil patent litigation
1 Mar 2008 by zeligasa  
the patent was for “a new о± crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it” (perindopril being an ace inhibitor used in the treatment of hypertension). ...
Zeligasa's Weblog - http://zeligasa.wordpress.com/

south africa: generics trial next week!!
30 Jan 2009 by Darren Olivier  
tim ball (patent litigation specialist at brian bacon & associates) has informed afro-ip of a showdown in the court of the commissioner of patents next week, providing a useful summary pre hearing: "the case of les laboratoires servier ...
Afro-IP - the blog for intellectual property... - http://afro-ip.blogspot.com/ - References

No prescription plendil 10mg order
7 Dec 2009 by admin  
Supplements center, these companies, or litigation middlemen, have measures that work areas for trend twitter. Buy no prescription generic perindopril 4mg, they are about european for dating and bringing soil acceptance students. ...
Dr Zord's Blog - http://jochenmoser.com/

low-priced levitra tramadol ultram viagra
6 Sep 2008
aceon and perindopril information news and information on aceon, atgorneys and lawyers af zyprexa, dgugwatch unsafe producys cereal recall, crib rrecall, flammable pr oducts, nachine. an attorney for epoven litigation, ...
emilylines - http://www.liveinternet.ru/users/emilylines/

IP finance ... where money issues meet intellectual property ...
16 Jan 2009 by Jeremy  
"Many years ago I was prescribed a daily dose of the ACE innhibitor, perindopril. As a result I have had a personal interest in the litigation associated with it. Originally my packets were labelled COVERSYL, which is the trade mark of ...
IP finance ... where money issues meet... - http://ipfinance.blogspot.com/ - References
[ More results from IP finance ... where money issues meet... ]

ip think tank global week in review - 25 april 2008
10 May 2008 by Law Bites  
... astelin and optivar (azelastine) – us: meda settles litigation brought against apotex to protect markets for optivar and astelin: (ip law360), (genericsweb),; coversyl (perindopril) – australia: perindopril polymorph opposition ...
Law Bites - http://lawbites.com/ - References
[ More results from Law Bites ]

a patent infringement claim
12 Aug 2009 by Breth  
in relation to the balance of convenience, it was argued that if the defendants were its generic product before the outcome of litigation, the national health service (nhs) the pricing policies associated with the requirements of the ...
Legal and Patent - http://legalandpatent.blogspot.com/

Pharmaceutical Lifecycle Management & IP acquisitions (IP Think ...
22 Oct 2007 by duncan@duncanbucknell.com (Duncan Bucknell)  
A classic example of this was Servier's acquisition of a host of Perindopril (Coversyl) patents owned by Lupin last April. Here's an example of a generic company innovating around the synthetic process, filing patents and realising their commercial ... I agree that it is quite interesting to watch fluctuations of company and asset values based on 3rd party IP litigation. Planning for this and optimising it should really be a core component of a good IP Strategy. ...
Duncan Bucknell's site updates - http://duncanbucknell.com/blog - References
[ More results from Duncan Bucknell's site updates ]

Europe launches pharma competition crackdown - Pharmafocus.com
11 Jul 2009
These companies - Krka, Lupin, Matrix Labs (a subsidiary of Mylan), Niche Generics and Teva are accused of agreeing deals with Servier to delay the launch of generic versions of its blood pressure treatment of Coversyl (perindopril). These companies - Krka, Lupin, Matrix Labs (a ... One conclusion that is not a matter of disagreement or controversy is the need to establish a single EU community patent and a unified specialised patent litigation system in Europe. ...
Pharmafocus.com Newsfeed - http://www.pharmafocus.com/cda/focusH

Stay up to date on these results:




 
  

Google Home - About Google Blog Search Beta - Information for Blog Authors

©2009 Google